padova trial: prasinezumab in early parkinson's disease
Published 1 year ago • 446 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
2:53
padova study: prasinezumab in patients with early parkinson's disease
-
1:24
pasadena trial: prasinezumab in early parkinson's disease
-
0:55
open label extension of prasinezumab in parkinson's disease: 1 year updates
-
1:29
prasinezumab: an anti-alpha-synuclein antibody in parkinson's disease
-
1:57
update on the pasadena trial of prasinezumab for parkinson's disease
-
2:12
key clinical trials of disease modifying therapies in parkinson's disease
-
2:03
what is the future of immunotherapy in parkinson’s disease?
-
13:48
a post-hoc analysis of the prasinezumab trial in early parkinson's disease
-
1:49
learnings from the pasadena trial in parkinson's disease
-
2:43
update on parkinson’s disease clinical trials
-
2:21
what have clinical trials taught us about parkinson's disease?
-
8:15
pasadena prasinezumab 12 month data
-
2:04
cinpanemab in early parkinson's disease | nejm
-
33:49
could prasinezumab be reducing motor progression in the pasadena open-label extension? -rallying 23
-
2:02
phase i study of selnoflast to slow neurodegeneration in parkinson's disease
-
3:21
developments in parkinson’s disease research and pasadena clinical trial update
-
1:10
updates on α-synuclein as a biomarker in parkinson's disease
-
1:36
parkinson's disease: updates in the disease-modifying space
-
1:38
assessing the efficacy of antibodies targeting α-synuclein